Research focuses on human cardiac organoids to uncover metabolic drivers of heart failure and accelerate new therapeutic strategies to improve cardiovascular outcomes SINGAPORE — Agilent Technologies Inc. (NYSE: A) announced the signing of a five-year Memorandum of Understanding (MOU) with National Heart Centre Singapore (NHCS) to accelerate innovation in metabolic heart failure research, one of the most […]
MARKHAM, Ontario — Alpha Controls & Instrumentation Inc. (“Alpha Controls”), a leading Canadian distributor of instrumentation and provider of calibration, validation and process-control solutions, is pleased to welcome Hamilton to its supplier network, reinforcing the company’s commitment to delivering world-class laboratory equipment, analytical instruments, and bioprocess monitoring solutions to the Canadian market. As Alpha Controls continues to expand […]
MOUNT PLEASANT, SC, UNITED STATES — Efferent Labs, an innovator in real-time biosensor systems that enable continuous biological monitoring, has announced the appointment of Philip D. Manos as Chief Science Officer. The company’s breakthrough technology could dramatically reduce reliance on animal testing and transform how drugs are discovered and diseases are monitored. Manos will lead the scientific […]
Patent strengthens 3D Ready™ portfolio, enabling consistent, assay-ready organoids for predictive drug discovery SAN JOSE, Calif. – Molecular Devices, LLC., a leading provider of high-performance life science solutions, today announced the issuance of U.S. Patent No. 12,351,820 B2, titled “Methods for Culturing Organoids.” The patent covers aspects of the company’s novel bioreactor-based method for producing organoids. Molecular Devices’ […]
Kit offers novel protein interactomics analysis of immune cells MORRISVILLE, N.C. and STOCKHOLM — Carolina Molecular Inc., a leading molecular testing services laboratory, and Pixelgen Technologies AB announced today a partnership to expand access to cutting-edge 3D protein interactomics capabilities to researchers and clinicians in the United States. Carolina Molecular will be the first certified U.S. service provider for […]
Collaboration will investigate how continuous flow cellular engineering and donor-to-dose manufacturing expertise may advance scalable, non-viral processes for next-generation cell therapies. CAMBRIDGE, Mass. and SAN DIEGO, Calif. — Kytopen Corp., a leader in continuous flow cellular engineering, and Excellos, Inc., a cell therapy CDMO and member of Blood Centers of America (BCA), today announced that the two […]
Company initiates search for successor ROCKVILLE, Md. — MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that Chief Financial Officer Douglas Swirsky has informed the Company of his decision to transition from his role in the first […]
Landmark dataset aims to transform understanding of immune-driven illness and accelerate drug discovery SAN FRANCISCO & SEATTLE — Third Rock Ventures and Parse Biosciences today announced a strategic collaboration to create an unprecedented atlas of 5 million T cell receptors (TCRs) using Parse Biosciences’ GigaLab platform. The project is led by a stealth Third Rock […]
Schlieren, Switzerland — InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed the definitive agreement to acquire DOPPL SA, a Lausanne-based innovator in the organoid space, including the Sun Bioscience Gri3D® technology. The acquisition strengthens InSphero’s position as the most comprehensive provider of advanced 3D in vitro models, combining scalable spheroid and organoid technologies with integrated assay […]
Framingham, MA – Ensorcell, the newest company to emerge from Re:Build Manufacturing, has officially launched operations in Framingham, Massachusetts. Ensorcell evaluates critical research and bioprocess technologies to develop innovative, intuitive and cost-effective solutions. Research, development and manufacturing are all United States-based, drawing from the vast network of cross-sector engineering and operations expertise in the Re:Build Manufacturing ecosystem. “At Re:Build […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
